期刊文献+

甲状腺乳头状癌伴远处转移的临床分析

原文传递
导出
摘要 甲状腺癌是人体内分泌系统最常见的恶性肿瘤.在世界范围内发病率呈上升趋势。甲状腺癌在所有恶性肿瘤中占1.0%-1.5%.其中甲状腺乳头状癌(papillary thyroid carcinoma.PTC)是最常见的一种.其发病率占全部甲状腺癌的60%~80%,由于其癌细胞分化程度高,大多数病人预后较好。在临床上PTC淋巴结转移多见.而血行远处转移比较少见.也少有相关报道,
出处 《外科理论与实践》 2014年第3期256-259,共4页 Journal of Surgery Concepts & Practice
  • 相关文献

参考文献13

  • 1孙庭钰,钱敏飞,王家东.甲状腺乳头状癌原发灶手术范围的现状及研究[J].临床耳鼻咽喉头颈外科杂志,2008,22(18):862-864. 被引量:3
  • 2Haigh PI,Urbach DR,Rotstein LE.Extend ofthyroidectomy is not a majordeterminant of survival in low-or high-risk papillary thyroid carcinoma[J].Ann Surg Oncol,2005,12(1):81-89.
  • 3Kim JM,Kim TY,Kim WB,et al.Lymphovascular invasionis associated with lateral cervical lymph node metastasis inpapillary thyroid carcinoma[J].Laryngoscopy,2006,116(11):2081-2085.
  • 4孙彦,王琪.2002年AJCC甲状腺癌分期方案[J].国外医学(耳鼻咽喉科学分册),2004,28(6):385-386. 被引量:11
  • 5Weber T,Schilling T,Buchler MW.Thyroid carcinoma[J].Curr Opin 0ncol,2006,18(1):30-35.
  • 6吴延升,张仑,王旭东,张文超.甲状腺乳头状癌预后多因素分析[J].中国肿瘤临床,2007,34(22):1294-1297. 被引量:34
  • 7Verburg FA,de Keizer B,Lips CJ,et al.Prognosticsignificance of successful ablation with radioiodine ofdifferentiated thyroid cancer patients[J].Eur J Endocrinol,2005,152(1):33-37.
  • 8Cooper DS,Doherty GM,Haugen BR,et al.RevisedAmerican Thyroid Association management guidelines forpatients with thyroid nodules and differentiated thyroidcancer[J].Thyroid,2009,19(11):1167-1214.
  • 9Durante C,Haddy N,Baudin E,et al.Long-term outcomeof 444 patients with distant metastases from papillary andfollicular thyroid carcinoma:benefits and limits ofradioiodine therapy[J].J Clin Endocrinol Metab,2006,91(8):2892-2899.
  • 10Leight Jr GS.Nodular poiter and benign and malignantneoplasms of the thyroid[M]//Leight Jr GS.Sabiston TextBook of Surgery.15th ed.philadelphia:W.B.Saunders,1997:626-637.

二级参考文献36

  • 1孙彦,王琪.2002年AJCC甲状腺癌分期方案[J].国外医学(耳鼻咽喉科学分册),2004,28(6):385-386. 被引量:11
  • 2钱碧云,陈可欣,何敏,董淑芬,韩宏伟,雷蕾,王继芳.天津市区甲状腺癌流行状况调查[J].中国肿瘤临床,2005,32(4):218-221. 被引量:56
  • 3王深明,叶财盛,李晓曦,刘仁斌,黄雪玲,叶洁莲.无转移分化型甲状腺癌首次手术范围的选择[J].中华外科杂志,2007,45(3):182-185. 被引量:23
  • 4JEMAI. A, SIEGEl. R, WARD D, et al. Cancer statistics 2007[J]. CA Cancer J Clin, 2007, 57:43-46.
  • 5HUNDAHL S A, FLEMING I D, FREGEN A M, et al. A national cancer data base report on 53856 cases of thyroid carcinoma treated in the United States[J]. Cancer, 1998, 83:2638-2648.
  • 6MAZZAFERRI E L, KLOOS R T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab, 2001, 86:1447--1463.
  • 7MARIA R P, ISABELLA M B, ANTONIO T, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients[J]. Clinical Nuclear Medicine, 2007, 32:440--444.
  • 8LIN J D, CHAO T C, CHOU S C, et al. Papillary thyroid carcinomas with lung metastases [J]. Thyroid, 2004, 14:1091--1096.
  • 9TORRENS J I, BURCH H B. Serum thyroglobulin measurement: utility in clinical practice[J]. Endocrinol Metab Clin North Am , 2001, 30:429--467.
  • 10PACINI F, MOLINARO E, LIPPI F, et al. Prediction of disease status by recombinant human TSH- stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 2001, 86:5686--5690.

共引文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部